Gruss Capital Management’s Allergan plc AGN Stock Holding History

Gruss Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-415,000	Closed	-$95.9M	–	46
2016 Q2	$95.9M	Buy	+415,000	New	+$95.7M	3.09%	8

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gruss Capital Management's AGN Position: Q4 2016 in Review

Gruss Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 415,000 shares — an estimated $86M sold.

Gruss Capital Management first reported a position in AGN in Q2 2016 and held it in 2 quarters. The position peaked at $95.9M in Q2 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

Gruss Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
Gruss Capital Management sold 415,000 Allergan plc shares in Q4 2016, an estimated $86M.
Gruss Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 2 quarters.
Gruss Capital Management's Allergan plc position peaked at $95.9M in Q2 2016.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Gruss Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.